Plus   Neg

Merck To Acquire Peloton - Quick Facts

Merck (MRK) has reached an agreement with Peloton Therapeutics, Inc., under which a Merck unit will acquire Peloton for an upfront payment of $1.05 billion. Peloton shareholders will receive a further $1.15 billion on achievement of certain milestones.

Peloton Therapeutics is a clinical-stage biopharmaceutical company focused on the development of small molecule therapeutic candidates for the treatment of patients with cancer and other non-oncology diseases. Peloton's lead candidate PT2977, an oral HIF-2a inhibitor, is in late-stage development for renal cell carcinoma.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A survey has shown that while a majority of Americans want to buy a car that contributes substantially to the U.S. economy amid rising trade tensions, most of the "American-made" cars are actually produced by foreign automakers. According to Cars.com's 2019 American-Made Index, the most 'American-made' vehicle in 2019 is the Jeep Cherokee. Streaming giant Netflix Inc. (NFXL) is set to lose the right to stream "The Office," one of the most popular TV show on the service. NBC Universal announced it is taking back the popular TV show for its own streaming platform, beginning January 2021. "We're sad that NBC has decided to take The... Chinese smartphone maker Xiaomi has announced that its recently launched Mi Band 4 crossed 1 million units sales in just eight days. Xiaomi's Director of Product Management Donovan Sung tweeted this news as he thanked Mi fans for the achievement. "Sharing some great news with our global Mi Fans....
Follow RTT